A. Schulman Launches its Next Generation Styrene-Free SMC LYTEX™ SF
Oct 02, 2017 20:59 pm UTC| Business
AKRON, Ohio, Oct. 02, 2017 -- A. Schulman Inc. (Nasdaq:SHLM), a leading international supplier of high-performance plastic compounds, composites, powders, and resins, today announced the launch of its LYTEXTM SF series,...
Oct 02, 2017 20:50 pm UTC| Business
Washington, D.C, Oct. 02, 2017 -- In response to last evening’s mass shooting in Las Vegas, U.S. Conference of Mayors President and New Orleans Mayor Mitch Landrieu released the following statement: ...
McGrath RentCorp Sets Third Quarter 2017 Financial Results Date and Time
Oct 02, 2017 20:50 pm UTC| Business
LIVERMORE, Calif., Oct. 02, 2017 -- McGrath RentCorp (NASDAQ:MGRC) (the “Company”), a diversified business-to-business rental company, today announced plans to release financial results for its third quarter ending...
Farmer Brothers Completes Acquisition of Boyd Coffee Company
Oct 02, 2017 20:47 pm UTC| Business
NORTHLAKE, Texas, Oct. 02, 2017 -- Farmer Bros. Co. (NASDAQ:FARM) (“Farmer Brothers” or the “Company”) a national coffee roaster, wholesaler and distributor of coffee, tea and culinary products announced today that it...
Fibrocell to Present at 2017 Cell & Gene Meeting on the Mesa
Oct 02, 2017 20:30 pm UTC| Business
EXTON, Pa., Oct. 02, 2017 -- Fibrocell Science, Inc., (NASDAQ:FCSC) today announced that John Maslowski, President and Chief Executive Officer of Fibrocell, will present at 3:00 pm PDT on Wednesday, October 4 at the...
Esperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic Acid
Oct 02, 2017 20:30 pm UTC| Business
– Pivotal Phase 3 Top-Line Results for Bempedoic Acid Expected in the Second and Third Quarters of 2018 –– NDA Submission for LDL-C Lowering Indication for Bempedoic Acid Planned by First Quarter 2019 – ANN ARBOR, Mich.,...
Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 02, 2017 20:30 pm UTC| Business
DUBLIN, IRELAND, Oct. 02, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...